Trial
NCT00603785
Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
University of Chicago
Condition
Chronic Sinusitis
Intervention
Placebo
Why stopped
Insufficient funds available
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-05